Suppr超能文献

c-Abl 通过 ERKs 调节胃肠道肌间层稳态。

c-Abl regulates gastrointestinal muscularis propria homeostasis via ERKs.

机构信息

Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, 200240, China.

Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.

出版信息

Sci Rep. 2017 Jun 15;7(1):3563. doi: 10.1038/s41598-017-03569-0.

Abstract

The gastrointestinal tract is responsible for food digestion and absorption. The muscularis propria propels the foodstuff through the GI tract and defects in intestine motility may cause obstruction disorders. Our present genetic studies identified non-receptor tyrosine kinase c-Abl as an important regulator of the muscularis propria homeostasis and a risk factor for rectal prolapse. Mouse deficient for c-Abl showed defects in the muscularis propria of gastrointestinal tract and older c-Abl mice developed megaesophagus and rectal prolapse. Inhibition of c-Abl with imatinib mesylate, an anti-CML drug, or ablation of c-Abl using Prx1-Cre, which marks smooth muscle cells, recapitulated most of the muscularis propria phenotypes. The pathogenesis of rectal prolapse was attributable to overproliferation of smooth muscle cells, which was caused by enhanced ERK1/2 activation. Administration of ERK inhibitor U0126 impeded the development of rectal prolapse in c-Abl deficient mice. These results reveal a role for c-Abl-regulated smooth muscle proliferation in the pathogenesis of rectal prolapse, and imply that long-term use of imatinib mesylate may cause gastrointestinal problems in patients while ERK inhibitor may be effective in treating rectal prolapse.

摘要

胃肠道负责食物消化和吸收。固有肌层推动食物通过胃肠道,肠道运动功能障碍可能导致梗阻性疾病。我们目前的遗传研究确定非受体酪氨酸激酶 c-Abl 是固有肌层稳态的重要调节剂,也是直肠脱垂的危险因素。c-Abl 缺陷的小鼠表现出胃肠道固有肌层缺陷,年老的 c-Abl 小鼠发展为巨食管和直肠脱垂。用伊马替尼(一种抗 CML 药物)抑制 c-Abl 或使用标记平滑肌细胞的 Prx1-Cre 消融 c-Abl,可重现大部分固有肌层表型。直肠脱垂的发病机制归因于平滑肌细胞的过度增殖,这是由 ERK1/2 激活增强引起的。ERK 抑制剂 U0126 的给药可阻止 c-Abl 缺陷小鼠直肠脱垂的发展。这些结果揭示了 c-Abl 调节的平滑肌增殖在直肠脱垂发病机制中的作用,并表明伊马替尼的长期使用可能会导致患者出现胃肠道问题,而 ERK 抑制剂可能对治疗直肠脱垂有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/422c/5472598/9775293165fa/41598_2017_3569_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验